The licence for the #COVID19 serological antibody technology will be royalty-free for low- & middle-income countries & will remain valid until the date the last patent expires. @CSIC will provide all know-how to @MedsPatentPool &/or to prospective licensees as well as training. pic.twitter.com/OZPtKhvZOO— World Health Organization (WHO) (@WHO) November 23, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


